BEAUMONT HOSPITAL, ROYAL OAK TREATS ITS FIRST PATIENTS WITH ELEKTA AXESSE™

BEAUMONT HOSPITAL, ROYAL OAK TREATS ITS FIRST PATIENTS WITH ELEKTA AXESSE™

PRESS RELEASE	
Los Angeles, CA, October 30, 2007


Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first
treatments using the new Elekta Axesse™, the ultimate whole-body cancer
treatment system. Elekta Axesse sets new standards for precision and therapeutic
efficacy in stereotactic radiation therapy, which involves three-dimensional CT
imaging for tumor targeting accuracy. The new robotic, image-guided stereotactic
radiation system treats cancer patients quickly and effectively with highly
accurate tumor targeting

Since 2006, Beaumont Hospital has been running a successful intracranial
radiosurgery program with Leksell Gamma Knife, and the hospital now is expanding
its stereotactic treatment offerings to all parts of the anatomy. 

“We chose Elekta Axesse because of its versatility,” says Alvaro Martinez, M.D.,
F.A.C.R., corporate chairman, Radiation Oncology, Beaumont Hospitals. “We now
can stereotactically treat both intra- and extra-cranial lesions, and the 6D
robotically-controlled tabletop gives us the freedom to position the patient at
virtually any angle. This enables a much more accurate and precise treatment for
these lesions than we could provide in the past.” 

Integrating advanced technology and software to elevate the patient experience,
streamline clinician workflow

The advanced 3D imaging capabilities of Elekta Axesse facilitate rapid, precise
targeting of tumors, and the highly-conformal radiation delivery system
effectively treats tumors while minimizing damage to patients' healthy tissue. 

“Elekta Axesse enables us to attain sub-millimeter accuracy by planning in 3D
and imaging patients in 3D prior to treatment, every day,” says Dr. Martinez. 

Elekta Axesse also integrates non-invasive patient immobilization to ensure
patients properly are positioned prior to treatment. Working together, these
advanced technologies can mean fewer trips to the hospital for patients and less
physical, mental and emotional strain. 

In addition, by marrying advanced technology with sophisticated
software—including one unified display monitor with treatment planning,
electronic medical record (EMR) technology, and system controls—Elekta Axesse
smoothes the radiation therapist's workflow so patients are often finished with
their treatments more quickly. 

Shortened treatment times for many tumor sites throughout the body

The first patient treated on September 10 with Elekta Axesse underwent radiation
therapy for breast cancer. “The patient required extremely precise and accurate
treatment twice per day for one week,” says Dr. Martinez. “That's a
significantly shorter time period than the traditional seven weeks for this type
of case.”

The Elekta Axesse at Beaumont is now in routine clinical use for lung and spinal
radiosurgery, as well as for other clinical sites requiring high accuracy and
precision. “We have treated a patient who has recurrent cancer around the spinal
cord,” says Dr. Martinez. “Elekta Axesse is the only possible treatment option
remaining for the patient to prevent damage to the spinal cord that could leave
the patient paralyzed.” 

A third patient has metastases in the adrenal gland. Elekta Axesse can treat the
adrenal gland without harming the kidney, small bowel or spinal cord.” 

Elekta Axesse also is designed for treatment of prostate cancer. “We now have
robotic control to target the radiation more accurately to the prostate,” says
Dr. Martinez.

Elekta Axesse has performed well thus far in all treatments, he adds, with an
accuracy of within one millimeter. 

Elekta Axesse provides complete clinical solutions

The innovative new Elekta Axesse provides the world's most complete portfolio of
stereotactic, image-guided treatment solutions with a powerful combination of
accuracy, flexibility and dose control. Dr. Frank Vicini, M.D., chief of
Oncology, Beaumont Cancer Institute, Beaumont Hospitals, says the
three-dimensional kV volumetric imaging greatly improves the accuracy of tumor
targeting. “Elekta Axesse is highly accurate because the real-time imager
enables us to adjust, at the time of treatment, the shape and intensity of the
radiation delivered.”

Flexibility is vital to any successful radiation treatment, says Dr. Vicini.
Elekta Axesse allows for multiple energy options and beam shaping options for
efficient dose delivery and optimal target conformality, so healthy tissue is
spared. “Quite simply, Elekta Axesse offers better cancer control and fewer side
effects,” Dr. Vicini says. 

A history of technological collaboration

Beaumont Hospital, Royal Oak physicians have a nearly 20-year history of
partnering with the Elekta R&D team. The hospital has made vital contributions
to the development of pioneering 3D imaging and treatment technology. “We have
done research together that has contributed to the development of Elekta
Synergy® and Elekta Axesse, and we continue to be strong partners in advancing
treatment for patients,” Dr. Martinez says.


******



For further information, please contact:


Investor inquires:
Peter Ejemyr, Group VP Corporate Communications
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com


Media inquiries: 
Michelle Lee, PR and Advertising Manager, 
Tel: +1 770-670-2447, e-mail: michelle.lee@elekta.com

Global Marketing inquiries: 
Peter J. Gaccione, Vice President, Global Marketing, 
Tel:  +1 770-670-2380, e-mail: peter.gaccione@elekta.com
About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 4,500 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.